and specimen validity markers — all in one compact cup
Positive results should be confirmed using a laboratory method such as GC/MS or LC/MS in accordance with your testing program requirements
• Optional specimen validity/adulteration testing (configuration dependent)
Check to see if a line is visible at the Control Line labeled “C” on the device
• Single-panel screening for WKR (kratom / mitragynine)• One-step dip card design — no instrumentation required• Fast visual results — read in about 5 minutes• Compact
Indicaid COVID-19 (POC)Antigen Rapid Test Rapid Drug Test and specimen validity markers —CLIA license Required to purchase this product Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U. S. C. 263a, that meet the requirements to perform moderate complexity, high complexity, or waived tests. This test is authorized for use at the Point of Care (POC), i. e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of